Cargando…

Emerging Vaccine Technologies

Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emerge...

Descripción completa

Detalles Bibliográficos
Autores principales: Loomis, Rebecca J., Johnson, Philip R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494353/
https://www.ncbi.nlm.nih.gov/pubmed/26343196
http://dx.doi.org/10.3390/vaccines3020429
_version_ 1782380076351881216
author Loomis, Rebecca J.
Johnson, Philip R.
author_facet Loomis, Rebecca J.
Johnson, Philip R.
author_sort Loomis, Rebecca J.
collection PubMed
description Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emergence of new technologies with a growing understanding of host-pathogen interactions and immunity may lead to efficacious vaccines against pathogens, previously thought impossible.
format Online
Article
Text
id pubmed-4494353
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-44943532015-08-31 Emerging Vaccine Technologies Loomis, Rebecca J. Johnson, Philip R. Vaccines (Basel) Review Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emergence of new technologies with a growing understanding of host-pathogen interactions and immunity may lead to efficacious vaccines against pathogens, previously thought impossible. MDPI 2015-05-26 /pmc/articles/PMC4494353/ /pubmed/26343196 http://dx.doi.org/10.3390/vaccines3020429 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Loomis, Rebecca J.
Johnson, Philip R.
Emerging Vaccine Technologies
title Emerging Vaccine Technologies
title_full Emerging Vaccine Technologies
title_fullStr Emerging Vaccine Technologies
title_full_unstemmed Emerging Vaccine Technologies
title_short Emerging Vaccine Technologies
title_sort emerging vaccine technologies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494353/
https://www.ncbi.nlm.nih.gov/pubmed/26343196
http://dx.doi.org/10.3390/vaccines3020429
work_keys_str_mv AT loomisrebeccaj emergingvaccinetechnologies
AT johnsonphilipr emergingvaccinetechnologies